Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 73 clinical trials
Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department

(Apixaban rivaroxaban, dabigatran ...) should profoundly change the management of venous thromboembolism and cardioembolic event. Because of their risk-benefit, simplicity and convenience of their

  • 0 views
  • 21 Jan, 2021
Pilot Study: Comparison of Patients' Knowledge of Direct Oral Anticoagulants Between 2 Cardiology Departments Offering or Not a Pharmaceutical Interview

Direct oral anticoagulants (Rivaroxaban, Apixaban and Dabigatran) are an alternative to anti-vitamin K drugs and low molecular weight heparins in many cardiovascular diseases. This new

fibrillation
apixaban
thrombosis
clot
anticoagulants
  • 0 views
  • 20 May, 2021
  • 2 locations
'Understanding the Electrophysiological Substrate Underlying Persistent Atrial Fibrillation Study II (USURP AF- Study II)'

Atrial fibrillation (AF) is the most common type of chronic heart rhythm disease worldwide, with significant associated co-morbidities. Although there have been advances in understanding the mechanisms of AF, the underlying cause of AF and factors which perpetuate it remain incompletely understood. This is particularly the case for persistent AF …

ablations
persistent atrial fibrillation
pulmonary vein isolation
catheter ablation
paroxysmal atrial fibrillation
  • 1 views
  • 10 May, 2021
  • 1 location